In conclusion, DCPH alleviates gastric mucosal injury via regulating autophagy and targeting TLR4/NF-κB/NLRP3, thereby offering insights for the treatment of gastrointestinal diseases. This evidence concerns the gene NFKB1 and gastrointestinal disease.